Dermaseptin S4 (3-28)
General Information
DRACP ID DRACP02905
Peptide Name Dermaseptin S4 (3-28)
Sequence WMTLLKKVLKAAAKAALNAVLVGANA
Sequence Length 26
UniProt ID P80280
PubChem CID Not available
Origin Synthetic
Type Synthetic peptide
Classification
Active ACP
Activity Information
Cell Line | Disease | Cancer Classified | Activity | Assay | Testing Time | Literature |
---|---|---|---|---|---|---|
SW620 | Colon adenocarcinoma | Carcinoma | 54.02±3.37% Cytotoxicity=256 µg/ml | MTT assay | 3h | 1 |
Hemolytic Activity Human erythrocytes: 68.5±7.58% Hemolysis=256 µg/ml
Normal (non-cancerous) Cytotoxicity Not available
Target Not available
Affinity Not available
Mechanism Not available
Nature Anticancer; Antibacterial
Structure Information
Helicity Not available
Linear/Cyclic Linear
Disulfide/Other Bond Not available
N-terminal Modification Free
C-terminal Modification Amidation
Other Modification None
Chiral L
Physicochemical Information
Formula C123H213N33O30S
Absent amino acids CDEFHIPQRSY
Common amino acids A
Mass 311246
Pl 11.28
Basic residues 4
Acidic residues 0
Hydrophobic residues 17
Net charge 4
Boman Index 1877
Hydrophobicity 89.62
Aliphatic Index 139.23
Half Life
Mammalian: 4.4 hour
Yeast: >20 hour
E.coli: >10 hour
Extinction Coefficient cystines 5500
Absorbance 280nm 220
Polar residues 4
Amino acid distribution
Literature Information
Literature 1
Pubmed ID 33774792
Title Evaluating the effect of dermaseptin S4 and its derivatives on multidrug-resistant bacterial strains and on the colon cancer cell line SW620
Doi 10.1007/s11356-021-13683-2 Abstract
Year 2021
Patent
Patent ID Not available
Patent Title Not available
Other Iinformation Not available
Other Published ID Not available
External Code
DBAASP ID DBAASPS_18033